...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Safety evaluation of an alpha-cyclodextrin glycosyltranferase preparation.
【24h】

Safety evaluation of an alpha-cyclodextrin glycosyltranferase preparation.

机译:α-环糊精糖基转移酶制剂的安全性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Alpha-cyclodextrin glucosyltransferase (alpha-CGTase, EC 2.4.1.19) is an amylolytic enzyme used for the production of alpha-cyclodextrin (alpha-CD), a novel, soluble dietary fiber, from food-grade starch. The safety of an alpha-CGTase preparation obtained by batch fermentation from a recombinant strain of Escherichia coli K12 harboring the alpha-CGTase gene from Klebsiella oxytoca strain M5a1 was examined. In a 13-week subchronic toxicity study in rats, the administration by gavage of the alpha-CGTase preparation at levels of up to 20 ml/kg bw/day, corresponding to a total organic solids dosage of 260 mg/kg bw/day, did not cause any systemic toxic effect. Some signs of irritation were observed in the respiratory tract which occurred, however, in one sex only and/or were not dose-related. Accordingly, these changes were considered to be an unspecific consequence of the reflux and aspiration of the dosing solution. There was no evidence of a genotoxic activity in Ames tests and a chromosome aberration test in cultured human lymphocytes. It is concluded that the examined alpha-CGTase preparation is safe when used for the production of alpha-CD.
机译:α-环糊精葡萄糖基转移酶(α-CGTase,EC 2.4.1.19)是一种淀粉分解酶,用于从食品级淀粉生产α-环糊精(α-CD),一种新型的可溶性膳食纤维。检验了通过分批发酵从产自产酸克雷伯氏菌菌株M5a1的带有K-bGase基因的大肠杆菌K12重组菌株中获得的α-CGTase制剂的安全性。在一项为期13周的大鼠慢性亚慢性毒性研究中,通过管饲法对高达20 ml / kg bw /天的α-CGTase制剂进行了给药,相当于总有机固体剂量为260 mg / kg bw /天,没有引起任何全身毒性作用。在呼吸道中观察到一些刺激症状,但是仅在一种性别中和/或与剂量无关。因此,这些变化被认为是定量溶液回流和抽吸的非特异性结果。在Ames试验和培养的人类淋巴细胞中没有染色体毒性试验的证据。结论是,所检查的α-CGTase制剂用于生产α-CD时是安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号